Abstract
Gastrointestinal NursingVol. 10, No. 4 Conference ReportThe role of faecal calprotectin in IBDAndrew MilestoneAndrew MilestoneSearch for more papers by this authorAndrew MilestonePublished Online:16 Aug 2013https://doi.org/10.12968/gasn.2012.10.4.22bAboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareShare onFacebookTwitterLinked InEmail View article References Costa F, Mumolo MG, Ceccarelli L et al. (2005) Calprotectin is a stronger predictive marker of relapse in UC than in Crohn's disease. Gut 54: 364–8 Crossref, Google ScholarTibble J, Teahon K, Thjodleifsson B et al. (2000) IBD: a simple method for assessing intestinal inflammation in Crohn's disease. Gut 47: 506–13. doi:10.1136/gut.47.4.506 Crossref, Google Scholarvan Rheenen PF, Van de Vijver E, Fidler V(2010) Faecal calprotectin for screening of patients with suspected inflammatory bowel disease. BMJ 341: c3369. doi: 10.1136/bmj. c3369 Google Scholar FiguresReferencesRelatedDetails 1 May 2012Volume 10Issue 4ISSN (print): 1479-5248ISSN (online): 2052-2835 Metrics History Published online 16 August 2013 Published in print 1 May 2012 Information© MA Healthcare LimitedPDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
